GetTopicDetailResponse(id=738c9013961, topicName=補(bǔ)充性新藥申請(qǐng), introduction=補(bǔ)充性新藥申請(qǐng), content=null, image=null, comments=2, allHits=832, url=https://h5.medsci.cn/topic?id=90139, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98620, tagList=[TagDto(tagId=98620, tagName=補(bǔ)充性新藥申請(qǐng))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2034305, encodeId=ed84203430586, content=<a href='/topic/show?id=738c9013961' target=_blank style='color:#2F92EE;'>#補(bǔ)充性新藥申請(qǐng)#</a>, objectTitle=Toripalimab聯(lián)合化學(xué)療法一線治療鼻咽癌，中國(guó)國(guó)家藥品監(jiān)督管理局已批準(zhǔn)其補(bǔ)充性新藥申請(qǐng), objectType=article, longId=207388, objectId=e5a120e38811, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a120e38811, replyNumber=0, likeNumber=89, createdTime=2022-02-01, rootId=0, userName=xlysu, userId=3f54230, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a120e38811, moduleTitle=Toripalimab聯(lián)合化學(xué)療法一線治療鼻咽癌，中國(guó)國(guó)家藥品監(jiān)督管理局已批準(zhǔn)其補(bǔ)充性新藥申請(qǐng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e5a120e38811)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034304, encodeId=8e36203430476, content=<a href='/topic/show?id=738c9013961' target=_blank style='color:#2F92EE;'>#補(bǔ)充性新藥申請(qǐng)#</a>, objectTitle=美國(guó)FDA批準(zhǔn)補(bǔ)充性新藥申請(qǐng)（sNDA），擴(kuò)展MYCAMINE（注射用米卡芬凈）的適應(yīng)癥，用于治療小于4個(gè)月大的小兒侵襲性念珠菌血癥, objectType=article, longId=185991, objectId=6b1e18599136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b1e18599136, replyNumber=0, likeNumber=68, createdTime=2020-03-21, rootId=0, userName=xlysu, userId=3f54230, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b1e18599136, moduleTitle=美國(guó)FDA批準(zhǔn)補(bǔ)充性新藥申請(qǐng)（sNDA），擴(kuò)展MYCAMINE（注射用米卡芬凈）的適應(yīng)癥，用于治療小于4個(gè)月大的小兒侵襲性念珠菌血癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6b1e18599136)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
